News


( Last Updated : March 7, 2015)

August 17, 2020
Deliberative processes in health technology assessment (HTA) were the focus of the 2020 HTAi Global Policy Forum; this new article summarizes the discussions that were held over two days in January. Dr. Nicole Mittmann, Chief Scientist and Vice-President of Evidence Standards at CADTH, was one of…
July 13, 2020
A new project on Flash Glucose Monitoring System FreeStyle Libre to Monitor Glycemia in Patients With Diabetes is now available for feedback from all interested stakeholders. Flash Glucose Monitoring System FreeStyle Libre to Monitor Glycemia in Patients With Diabetes Call for Feedback: 2020-07-…
July 6, 2020
CADTH is proud to welcome Suzanne McGurn, who begins her role as President and Chief Executive Officer today. Ms. McGurn was appointed by the CADTH Board of Directors after a comprehensive search that was international in scope. She brings to CADTH significant leadership experience and a deep…
June 26, 2020
See Pharmaceutical Reviews Update – Issue 16 for important news and information related to CADTH’s drug review programs. Highlights from this issue include: a consultation on CADTH’s drug reimbursement review procedures a consultation on the Health Canada, CADTH, and INESSS aligned review process…
June 22, 2020
Canadian policy-makers face challenges with the number of drugs for rare indications and rapidly rising costs. In facing these challenges, decision-makers see real-world evidence (RWE) as an opportunity. Health Canada and CADTH recently announced the intent to co-develop an action plan to optimize…